| |
| |
|
| Insider
Information: |
Deerfield International Master Fund, L.p. |
| Relationship: |
*Director by Deputizat... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
285,000 |
|
|
Indirect Shares
|
28,566,834 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$92,646,360 |
|
|
| Total
Shares |
28,851,834 |
|
|
| Total
Value |
$92,646,360 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ehealth, Inc. |
EHTH |
Possible Members of 10... |
2014-08-01 |
0 |
2017-04-27 |
877,606 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
Possible Members of 10... |
2014-08-05 |
0 |
2014-08-05 |
627,267 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
Possible Members of 10... |
2014-08-06 |
0 |
2014-08-06 |
296,125 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2015-05-15 |
4,784,157 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Possible Member of 10%... |
2015-06-11 |
0 |
2015-07-20 |
9,500,803 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Possible Member of 10%... |
2016-02-09 |
0 |
2016-02-11 |
2,039,360 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Possible Member of 10%... |
2016-02-11 |
75,000 |
2016-02-19 |
9,414,041 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
10% Owner |
2016-02-17 |
210,000 |
|
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
*Director by Deputizat... |
2017-11-30 |
0 |
2017-11-30 |
1,027,475 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-11 |
4 |
S |
$11.01 |
$368,258 |
I/I |
(33,440) |
1,009,724 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-13 |
4 |
S |
$11.00 |
$1,650,000 |
I/I |
(150,000) |
975,375 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-26 |
4 |
S |
$11.52 |
$1,304,582 |
I/I |
(113,245) |
949,443 |
0 |
- |
|
| EHTH |
Ehealth, Inc. |
Possible Members of 10% Group |
– – • |
2017-04-27 |
4 |
S |
$11.71 |
$3,673,532 |
I/I |
(313,709) |
877,606 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
B |
$1.75 |
$193,475 |
I/I |
110,557 |
197,424 |
1.5 |
- |
|
| TARA |
Protara Therapeutics, Inc |
*Director by Deputization |
– – • |
2017-11-30 |
4 |
S |
$1.75 |
$193,475 |
I/I |
(110,557) |
0 |
0 |
- |
|
| XNPT |
Xenoport Inc |
10% Owner |
– – • |
2016-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,000 |
|
- |
|
| AVXS |
Avexis, Inc. |
10% Owner |
– – • |
2016-02-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
210,000 |
|
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2014-12-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,977,773 |
|
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2015-05-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,784,157 |
|
- |
|
| LRMR |
Larimar Therapeutics Inc |
10% Owner |
– – • |
2016-02-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,723,565 |
|
- |
|
61 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
